Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Automated Sample and Liquid Handling Platforms Suited for All Lab Sizes

By BiotechDaily International staff writers
Posted on 08 Jul 2014
Tecan Fluent laboratory automation solution
Automated Sample and Liquid Handling Platform (Photo courtesy of TECAN GROUP LTD.)
Biotech and other life scientists who work with cell-based assays now have available a new line of advanced automated sample and liquid handling platforms.

Tecan (Männedorf, Switzerland) has introduced the Fluent laboratory automation solution, the latest addition to its laboratory automation portfolio.

The Fluent system is available in three sizes—offering deck capacities from 30 to 72 microplates—to suit the throughput requirements of almost any laboratory. The instrument boasts a built-in touchscreen interface that guides users through every task, making even the most sophisticated cell-based assays easy to run. Fluent’s three, task-specific robotic arms work in parallel for faster processing, and offer automated lid handling to maintain sterility and minimize evaporation.

The Fluent platform was designed for integration with a variety of cell biology devices. This allows the user to control every step of the workflow, including storage, transfer, manipulation, and measurement of cellular samples on a single instrument.

The Tecan HydroSpeed plate washer features extra-gentle wash settings that can be adjusted to suit specific cells, microplates, and applications, ensuring reproducible results even with weakly adherent cells.

“Today’s research landscape looks different from yesterday’s, with customers wanting systems that are faster, more versatile, and more cost efficient,” said Dr. Stefan Traeger, head of life sciences business at Tecan. “The Fluent laboratory automation solution has initially been developed to address the needs of cell biology laboratories as they move towards greater miniaturization and higher throughput assays, and our test sites and assay partners have been impressed by its speed and capabilities for automating even complex cell-based assays.”

Related Links:

Tecan




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?


Channels

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.